| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 19, 2013 | Pechala's Reports | Lubomir Pechala | NXSTAGE MEDICAL INC (NXTM) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | NXSTAGE MEDICAL INC (NXTM) 12-months forecast | 1 | $15 | | May 16, 2013 | New Constructs, LLC | N/A | NXTM: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical Products | 17 | $195.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: LMAT , LMNX , MLAB , NXTM , PMTI , VRML -- MEDICAL SUPPLIES & EQUIPMENT | 3 | $34.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: NXSTAGE MEDICAL -- NXTM | 1 | $11.50 | | May 16, 2013 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of NXSTAGE MEDICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for NXTM | 11 | $126.50 | | May 11, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: NXSTAGE MEDICAL INC | 5 | $10 |
|
View All Reports for NXTM ... |
|
|
0.80%